Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VICToRY Trial
2023-504772-21-00Phase 2Completed
- Sponsor
- Queen's University
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 10
01
Overview
Phase 2, randomised, double-blind trial in thermal injury and burn injury comparing High-dose IV ascorbic acid with Placebo (D5W or NaCl solution) (2 arms). Primary endpoint: Persistent organ dysfunction (PODS) + death at 28 days. Started Jul 2023; status: completed.
02
Drugs
ascorbic acid
03
Conditions
thermal injuryburn injury
Beyond the preview
Go deeper on 2023-504772-21-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-504772-21-00.